UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 528

Sortiert nach

Pharmacology of Adenosine Receptors: The State of the Art

Physiological reviews, 2018-07, Vol.98 (3), p.1591-1625

2018

Link zum Volltext

Verfügbarkeit prüfen

Adenosine and Inflammation: Here, There and Everywhere

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7685

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8710

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathological overproduction: the bad side of adenosine

British journal of pharmacology, 2017-07, Vol.174 (13), p.1945-1960

2017

Link zum Volltext

Verfügbarkeit prüfen

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

Chemical reviews, 2016-01, Vol.116 (2), p.519-560

2016

Link zum Volltext

Verfügbarkeit prüfen

Glucocorticoid's pharmacology: past, present and future

Current pharmaceutical design, 2010-01, Vol.16 (32), p.3540

2010

Link zum Volltext

Verfügbarkeit prüfen

Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors

Biochemical pharmacology, 2010-02, Vol.79 (3), p.471-477

2010

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB2 receptor attenuates morphine‐induced inflammatory responses in activated microglial cells

British journal of pharmacology, 2012-08, Vol.166 (8), p.2371-2385

2012

Link zum Volltext

Verfügbarkeit prüfen

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1219

2022

Link zum Volltext

Verfügbarkeit prüfen

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Frontiers in pharmacology, 2017-10, Vol.8, p.744-744

2017

Link zum Volltext

Verfügbarkeit prüfen

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications

Frontiers in pharmacology, 2022-10, Vol.13, p.1030895-1030895

2022

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease

Molecules (Basel, Switzerland), 2022-04, Vol.27 (9), p.2680

2022

Link zum Volltext

Verfügbarkeit prüfen

Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-Like SH-SY5Y Cells from Oxygen-Glucose Deprivation

International journal of molecular sciences, 2020-10, Vol.21 (21), p.8053

2020

Link zum Volltext

Verfügbarkeit prüfen

A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

International journal of molecular sciences, 2022-05, Vol.23 (9), p.5056

2022

Link zum Volltext

Verfügbarkeit prüfen

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

Frontiers in pharmacology, 2018-06, Vol.9, p.632-632

2018

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

British journal of pharmacology, 2012-03, Vol.165 (6), p.1773-1788

2012

Link zum Volltext

Verfügbarkeit prüfen

An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

Frontiers in pharmacology, 2021-03, Vol.12, p.652455-652455

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Biological Properties, and Molecular Modeling Investigation of the First Potent, Selective, and Water-Soluble Human A3 Adenosine Receptor Antagonist

Journal of medicinal chemistry, 2002-08, Vol.45 (17), p.3579-3582

2002

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice

International journal of molecular sciences, 2022-07, Vol.23 (14), p.8030

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455

Frontiers in pharmacology, 2017-12, Vol.8, p.888-888

2017

Link zum Volltext

Verfügbarkeit prüfen

Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models

Pain (Amsterdam), 2013-06, Vol.154 (6), p.864

2013

Link zum Volltext

Verfügbarkeit prüfen

The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells

PloS one, 2012-06, Vol.7 (6), p.e39317-e39317

2012

Link zum Volltext

Verfügbarkeit prüfen

Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy

Pharmaceutics, 2023-10, Vol.15 (10), p.2441

2023

Link zum Volltext

Verfügbarkeit prüfen

A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?

Frontiers in pharmacology, 2020-12, Vol.11, p.625134-625134

2020

Link zum Volltext

Verfügbarkeit prüfen

A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease

Cells (Basel, Switzerland), 2021-09, Vol.10 (9), p.2344

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 528

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(499)
Mit Volltextzugriff
(506)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(157)
Science & Technology
(141)
Animals
(139)
Life Sciences & Biomedicine
(136)
Biological And Medical Sciences
(122)
Medical Sciences
(108)
Pharmacology. Drug Treatments
(102)
Pharmacology & Pharmacy
(92)
Neuropharmacology
(72)
Neurotransmitters. Neurotransmission. Receptors
(64)
Adenosine Receptors
(62)
Structure-Activity Relationship
(62)
Adenosine
(59)
Male
(58)
Rats
(50)
Cricetinae
(48)
Cho Cells
(46)
Peptidergic System . Adenosinergic And Purinergic Systems
(45)
Receptors, Purinergic P1 - Metabolism
(39)
Chemistry, Medicinal
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacology of Adenosine Receptors: The State of the Art

Adenosine and Inflammation: Here, There and Everywhere

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain

Pathological overproduction: the bad side of adenosine

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

Glucocorticoid's pharmacology: past, present and future

Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors

Cannabinoid CB2 receptor attenuates morphine‐induced inflammatory responses in activated microglial cells

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications

Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease

Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-Like SH-SY5Y Cells from Oxygen-Glucose Deprivation

A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

Synthesis, Biological Properties, and Molecular Modeling Investigation of the First Potent, Selective, and Water-Soluble Human A3 Adenosine Receptor Antagonist

In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice

Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455

Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models

The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells

Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy

A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?

A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease

Suchergebnisse filtern